Silent video


Nu-V3 is a patented and trademark registered neuromodulation device to treat pain, anxiety, depression and sleeplessness, which is miniature, wearable, non-invasive and non-pharmaceutical.  

Nu-Life USA is the exclusive provider of Nu-V3 throughout the United States and United States Territories.

Nu-Life USA
Neuromodulation by Nu-V3

Neuromodulation is technology that acts directly upon nerves. It is the alteration - or modulation - of nerve activity by delivering either electrical or pharma-ceutical (drug) agents directly to a target area. 

Nu-Life's Nu-V3 technology delivers a micro-electrical signal to create the cranial nerve stimulation non-invasively and non-pharmaceutically directly through the auricular (ear) area, all while allowing the patient to perform almost any everyday activity.

Inquire about The H.O.P.E. Initiative

Frequently Asked Questions

NOTE:  Nu-V3 is pre-regulatory clearance and anticipates full market entry in the United States, early 2021, followed by Europe, Japan, Latin America and Canada.

Information contained on this website is intended to educate the viewer about Nu-V3, how it works, our commitment to long term benefit for our patients and the results collected to date through IRB approved clinical trial.  Any use of Nu-V3, the Nu-V3 treatment program and initiatives such as The H.O.P.E. Initiative are for this purpose and are conducted under strict FDA guidelines and IRB approval.

The Top 3 - Latest News and Events

SM Icon LI.png
SM Icon FB.png